Advaxis, Inc. Georgia Regents Trials - San Diego, California News Station - KFMB Channel 8 -

Advaxis, Inc. Georgia Regents Trials

Posted: Updated:

Advaxis Inc. (NASDAQ:ADXS) today

published a new blog post on The Chairman’s Blog, written by the

company’s COO, Mr. Gregory T. Mayes. is an

exclusive online media publication that provides key executive

officers and key opinion leaders a unique platform to share insights

about company and industry trends.

Mr. Mayes blogs about the company’s

recently announced collaboration with GRU Cancer Center at Georgia

Regents University. In it, he speaks about how Advaxis plans on

expanding its existing relationship with GRU Cancer Center and Dr.

Khleif to harness “the power and strength of the caner

immunotherapy research at GRU.” Read the full blog post on


About Advaxis, Inc.

Advaxis is a

clinical-stage biotechnology company developing the next generation

of cancer immunotherapies. Advaxis immunotherapies are based on a

novel platform technology using live, attenuated bacteria that are

bio-engineered to secrete an antigen/adjuvant fusion protein(s) that

is designed to redirect the powerful immune response all human beings

have to the bacterium to the cancer itself.

ADXS-HPV is currently being evaluated

in Phase 1 and 2 clinical trials for HPV-associated cancers:

recurrent cervical cancer (completed Phase 2 study conducted in

India), locally advanced cervical cancer (GOG/NCI U.S. study,

Clinical Identifier NCT01266460), head & neck cancer

(CRUK study, Clinical Identifier NCT01598792, Mt. Sinai

study, Clinical Identifier NCT02002182), and anal cancer

(BrUOG U.S. study, Clinical Identifier NCT01671488).

Advaxis has over 15 distinct immunotherapies in various stages of

development, developed directly by Advaxis and through strategic

collaborations with recognized centers of excellence such as: the

University of Pennsylvania, the Georgia Regents University Cancer

Center, Icahn School of Medicine at Mount Sinai, and others.

For more information please visit:

About is an exclusive,

online media publication where publically and privatively held firms

alike share insights about their companies and industries. enables upper tier management to discuss issues

that are of importance to their stakeholders, shareholders, and

interested parties in an informal environment. In addition to

management`s insightful blog posts, staff and

aggregate partners contribute articles on finance, technology,

health, and energy while providing updated market trends, news, and



ReleaseID: 32789

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and Midwest Television, Inc. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.